SAM
RCUS icon

Sectoral Asset Management’s Arcus Biosciences RCUS Stock Holding History

Sectoral Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
45,070
-11,875
-21% -$256K 0.86% 29
2025
Q4 		$1.36M Sell
56,945
-311,125
-85% -$6.35M 1.09% 28
2025
Q3 		$5.01M Buy
368,070
+110,800
+43% +$1.15M 3.09% 6
2025
Q2 		$2.09M Buy
257,270
+230,400
+857% +$1.97M 1.38% 18
2025
Q1 		$211K Sell
26,870
-42,682
-61% -$495K 0.16% 70
2024
Q4 		$1.04M Sell
69,552
-5,970
-8% -$97.5K 0.69% 40
2024
Q3 		$1.15M Sell
75,522
-2,863
-4% -$45.1K 0.68% 46
2024
Q2 		$1.19M Sell
78,385
-15,250
-16% -$246K 0.49% 53
2024
Q1 		$1.77M Sell
93,635
-3,800
-4% -$65.7K 0.7% 46
2023
Q4 		$1.86M Sell
97,435
-278,021
-74% -$4.44M 0.8% 50
2023
Q3 		$6.74M Buy
375,456
+20,966
+6% +$421K 1.31% 26
2023
Q2 		$7.2M Buy
354,490
+60,844
+21% +$1.16M 1.2% 33
2023
Q1 		$5.36M Buy
293,646
+55,164
+23% +$1.05M 1.03% 41
2022
Q4 		$4.93M Buy
238,482
+11,450
+5% +$315K 0.95% 47
2022
Q3 		$5.94M Sell
227,032
-84,750
-27% -$2.24M 1.17% 32
2022
Q2 		$7.9M Sell
311,782
-26,698
-8% -$654K 1.59% 20
2022
Q1 		$10.7M Buy
338,480
+55,270
+20% +$1.85M 1.9% 15
2021
Q4 		$11.5M Sell
283,210
-455,800
-62% -$17.7M 1.73% 17
2021
Q3 		$25.8M Buy
739,010
+64,750
+10% +$2.02M 2.14% 4
2021
Q2 		$18.5M Sell
674,260
-184,950
-22% -$5.28M 1.5% 23
2021
Q1 		$24.1M Sell
859,210
-1,950
-0.2% -$67.9K 1.83% 14
2020
Q4 		$22.4M Sell
861,160
-61,640
-7% -$1.49M 1.58% 27
2020
Q3 		$15.8M Buy
+922,800
New +$20.6M 1.36% 30
2020
Q2 		– Sell
-261,213
Closed -$3.63M – 195
2020
Q1 		$3.63M Buy
+261,213
New +$3.25M 0.7% 54

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sectoral Asset Management's RCUS Position: Q1 2026 in Review

Sectoral Asset Management reduced its Arcus Biosciences (RCUS) stake by 21% in Q1 2026, selling an estimated $256K and leaving 45,070 shares worth $1.04M. The position accounts for 0.86% of the portfolio, ranked #29.

Sectoral Asset Management first reported a position in RCUS in Q1 2020 and has held it in 24 quarters since. The position peaked at $25.8M in Q3 2021. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Sectoral Asset Management held 45,070 shares of Arcus Biosciences worth $1.04M as of Q1 2026.
  • Sectoral Asset Management sold 11,875 Arcus Biosciences shares in Q1 2026, an estimated $256K.
  • Arcus Biosciences made up 0.86% of Sectoral Asset Management's portfolio in Q1 2026, its #29 holding.
  • Sectoral Asset Management first reported a position in Arcus Biosciences in Q1 2020 and has held it in 24 quarters since.
  • Sectoral Asset Management's Arcus Biosciences position peaked at $25.8M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.